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Abstract
Background and Aims
Cognitive bias modification (CBM) interventions, presumably targeting automatic pro-
cesses, are considered particularlypromising for addictions. We conducted a meta-analy-
sis examining randomized controlled trials (RCTs) of CBM for substance addiction
outcomes.
Methods
Studies were identified through systematic searches in bibliographical databases. We
included RCTs of CBM interventions, alone or in combination with other treatments, for any
type of addiction.We examined trial risk of bias, publication bias and possible moderators.
Effects sizes were computed for post-test and follow-up, using a random-effects model.We
grouped outcomemeasures and reported results for addiction (all relatedmeasures), crav-
ing and cognitive bias.
Results
We identified 25 trials, 18 for alcohol problems, and 7 for smoking. At post-test, there was
no significant effect of CBM for addiction, g = 0.08 (95%CI -0.02 to 0.18) or craving,
g = 0.05 (95%CI -0.06 to 0.16), but there was a significant, moderate effect on cognitive
bias, g = 0.60 (95%CI 0.39 to 0.79). Results were similar for alcohol and smoking outcomes
taken separately. Follow-up addiction outcomes were reported in 7 trials, resulting in a
small but significant effect of CBM, g = 0.18 (95%CI 0.03 to 0.32). Results for addiction and
craving did not differ by substance type, sample type, delivery setting, bias targeted or num-
ber of sessions. Risk of bias was high or uncertain in most trials, for most criteria consid-
ered. Meta-regression analyses revealed significant inverse relationships between risk of
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bias and effect sizes for addiction outcomes and craving. The relationship between cogni-
tive bias and respectively addiction ESs was not significant. There was consistent evidence
of publication bias in the form of funnel plot asymmetry.
Conclusions
Our results cast serious doubts on the clinical utility of CBM interventions for addiction
problems, but sounder methodological trials are necessary before this issue can be settled.
We found no indication that positive effects on biases translate into effects on addiction
outcomes.
Background
Despite mounting enthusiasm for cognitive bias modification over the last decade, expressed in
an explosion of studies and research programs [1], as well as highly laudatory reviews and dedi-
cated comments in top-tier journals [2,3] and exclusively positive coverage in the popular
media [4], the clinical effectiveness of these bias modification interventions has recently been
contested for anxiety and depression related outcomes, in both adult [5,6] and young popula-
tions [7]. Nonetheless, one of the fields where CBM is still considered as particularly promising
is that of addiction and substance use disorders, where studies have been accumulating during
the last years.
Cognitive bias modification (CBM) has been defined synthetically as the “direct manipula-
tion of a target cognitive bias, by extended exposure to task contingencies that favor predeter-
mined patterns of processing selectivity” [8] (p.191). CBM interventions are grafted on a dual
process model of addiction, which postulates that relatively automatic (impulsive) processes
surmount controlled (reflective) ones (see [9] for a review). In this framework, CBM interven-
tions are believed to effectively impact the impulsive processes, considered less amendable to
change within traditional psychological interventions. Two types of automatic processes in par-
ticular have been studied. The first refers to attentional biases, the preferential allocation of
attention resources to substance-related stimuli [10]. The second concentrates on presumably
automatically activated action tendencies of approaching addiction-related stimuli [9]. A num-
ber of procedures were developed to target each type of bias, mostly based on experimental,
computer-based tasks in which participants are trained, over more repetitions of pairs of sti-
muli, and usually without their explicit awareness, to either avoid directing attention to addic-
tion-related stimuli (attention bias modification/ABM)or to avoid approaching them
(approach-avoidance task/AAT).
In a recent review, Cox and colleagues [10] argued that ABM should be awarded “more
weight” for addiction disorders and that the preliminary evidence about its effectiveness, avail-
able so far, was “encouraging” (p.222). AAT was also judged as efficacious for reducing alcohol
use [11] and alcohol dependence [9]. Although a recent narrative review has voiced concerns
about the clinical potential of ABM in substance use disorders, drawing attention to methodo-
logical flaws and numerous negative findings [12], a systematic review examining the effective-
ness of these interventions for addiction has not yet been conducted. Consequently, our goal
was to conduct a meta-analysis examining all types of CBM interventions tested in randomized
controlled trials (RCTs) for addiction-related outcomes.
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PLOSONE | DOI:10.1371/journal.pone.0162226 September 9, 2016 2 / 19
Methods
Identificationand selection of studies
We conducted a comprehensive literature search (see S1 File. for the complete search string) in
Pubmed, PsychInfo, the Cochrane library and EMBASE throughMarch 2015. The search was
then updated on December 8th 2015, looking for studies published betweenMarch and Decem-
ber. We combined text words related to CBM interventions, ("cognitive bias", "attention bias",
"interpret bias" or "approach avoidance") and ("modification", "training", "practice", or "task")
with terms relating to addictions, ("addiction", "dependen", "alcohol", "drinking", "tobacco",
"nicotine”, "smoking", "drug", "cannabis", "marijuana", "cocaine", "heroin", "opiates", "amphet-
amine" or "substance use"). No MeSH terms were available. No filters were used as to not miss
any studies that might not have presented themselves as RCTs, but as experimental studies.
The reference sections of previous reviews were also checked for additional articles. There was
no registered protocol for this systematic review.
Included studies were: (a) randomized controlled trials (RCTs), comparing (b) a CBM inter-
vention, alone or in combination with another treatment (c) to a control group, another active
treatment, or a combination of treatments, (d) for addiction relevant outcomes, (e) published
in peer-reviewed journals.We did not apply any age or language restrictions.
We included studies employing a combination of a CBM intervention with another active
treatment (psychological or pharmacological), if there was a control condition for the CBM
intervention (i.e. a group that received no CBM intervention to decrease bias, whether that
meant no intervention, a placebo / no-contingency intervention, an intervention supposed to
achieve the reverse effect of increasing bias), whether it was alone or combined with another
active treatment. Simply put, the CBM intervention had to be different between the interven-
tion and control groups.
Active CBM interventions were defined as intending to decrease bias, regardless of its type
and consequently improve addiction relevant outcomes. Using only outcomes measured on
established, standardized instruments would have been preferable, but for craving many stud-
ies only reported outcomes on ad-hoc Likert-type or Visual Analogue Scales (VAS). Therefore,
we included these measures so as not to lose toomany studies from the analyses, but conducted
sensitivity analyses to verify whether results changed when exclusively considering established
and standardizedmeasures. We did not include outcomes that measured consumption or pref-
erences during a non-standardized behavioral test (i.e., participants were given an impromptu
taste test which measured whether they chose non-alcoholic over alcoholic drinks or how
much they consumed from each drink).We opted for this because this is a non-standardized
and variable task that does not take into account participants’ general preferences, their habit-
ual alcohol consumption, and that is usually carried out without their awareness. We did
include measures of consumption when they were reported on standardized self-report (e.g.,
The Timeline Follow-Back diary) or behavioral measures.
Power calculation
Based on previous narrative reviews and our own previous meta-analysis of CBM [7], we
expected a reduced number of studies and a small effect size. We conducted a power calcula-
tion [13] to determine howmany studies would have to be included to ensure enough statistical
power to identify relevant effects.We conservatively assumed a medium level of between-study
variance, τ2, a statistical power of 0.80, and a significance level, alpha, of 0.05. These calcula-
tions indicated that it would take at least 20 studies with a mean sample size of 30 (15 partici-
pants per condition) to be able to detect a small effect size of d = 0.30. Alternatively, we would
Cognitive Bias Modification for Addictions
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need to include 15 studies with a total mean number of 40 participants each to detect an effect
size of d = 0.30, or 14 studies with 50 participants.
Risk of bias (RoB) assessment and data extraction
As a proxy for methodological quality, we used five criteria of the CochraneCollaborations’s
Risk of Bias tool [14], developed to assess sources of bias in RCTs:
1. Adequate generation of allocation sequence
2. Concealment of allocation to conditions
3. Prevention of knowledge of the allocated intervention to assessors of outcome
4. Prevention of knowledge of the allocated intervention to participants
5. Dealing with incomplete data
Blinding of outcome assessors was rated as low risk of bias either if the study described
proper methods of ensuring blinding or if all outcome measures were self-report scales, thus
not requiring the interaction with an assessor. We also evaluated blinding of participants
because, unlike other psychological interventions, CBM is often carried out without making
participants aware of the purpose of the intervention, the particular contingency they are
exposed to, and in some cases, to the very fact they are being subjects of an intervention.More-
over, lack of participant awareness of the training contingencies was interpreted as evidence of
the implicit mechanism of action behind CBM interventions, believed to modify biases inacces-
sible to awareness [1,15]. We rated studies as having low risk of bias on this criterion only if the
authors explicitly measured participant awareness of training contingencies and reported that
less than 50% of the study participants were aware of their group allocation.
Dealing with incomplete data was rated as low risk of bias if there was no missing data or if
authors explicitly reported analyzing their data using the intent-to-treat (ITT) principle (i.e.,
all randomized participants were analyzed). Risk of bias was rated by two independent
researchers (IAC and RNK). Disagreements were discussed and if they remained unresolved,
the third author (PC) was consulted. Along with describing risk of bias for the included studies,
we also computed a “low risk of bias” score for each study, by awarding one point of each crite-
rion for which the study had low RoB. In this way, we obtained a total score for low risk of bias
for each study across the 5 criteria, which we used in meta-regression analyses.
As potential moderators, we extracted information about several aspects of the studies:
1. Addiction type: alcohol or smoking (there were no trials for other substances)
2. Participants: patients- diagnosed using a clinical interview (e.g., Composite International
Diagnostic Interview); substance consumers/users- selected for high values on a scale or for
self-reported frequent use of a substance
3. Delivery setting: laboratory; home/participant’s environment; mental health clinic
4. Type of bias intervention: attentional (ABM); approach-avoidance (AAT); response
inhibition
5. Number of sessions: as many studies had one session, we also coded this variable categori-
cally into single- and multi-session studies.
6. Type of outcome measure used: established, validated standardized instruments or tasks;
ad-hoc scales (Likert scales, Visual analogue scales); bias-related tasks or measures
Cognitive Bias Modification for Addictions
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Meta-analysis
Effect sizes (ESs) were computed for each comparison between a CBM intervention (alone or
in combination) and a comparison group as the difference between the 2 groups at posttest
and, respectively, follow-up (Cohen’s d or standardizedmean difference). The ESs were calcu-
lated by subtracting the mean score of the CBM group from the mean score of the comparison
group, and dividing the result by the pooled standard deviation of the two groups. It is gener-
ally accepted [16] that ESs of 0.2 are small, while ESs of 0.5, moderate and ESs of 0.8 and over,
large. Since many studies had small sample sizes, we reported the indicator corrected for small
sample bias [17], Hedges’ g.
We used the Comprehensive Meta-analysis software (CMA; version 2.2.064) for computing
and pooling individual effect sizes. As there was a lot of variability in the addiction outcomes
considered and the instruments used to measure them, we defined the following outcome cate-
gories: addiction (all outcomes related to addiction, regardless of the problem type, like habit-
ual use or desire, or the particular substance); and craving (all outcomes relating to craving or
desire for a substance, regardless of the substance).We also considered another category
related to bias outcomes, where we included all bias measures, regardless of the task or type
(avoid/attend or avoid/approach), as it is not clear which type of bias CBM interventions are
supposed to influence (i.e., increase avoidance of alcohol related stimuli or decrease attending/
approaching of these stimuli).
In the cases where a study usedmore than one outcome from the same pre-defined category
or if the same outcome was measured by more than one instrument, an average ES per study
was computed. When means and standard deviations for the relevant outcomes were not
reported in a study, we used the procedures implemented in CMA [18] to transform dichoto-
mous data into the standardizedmean difference, or other statistics such as t-values or exact p-
values to calculate the standardizedmean difference. If there was insufficient data for ES calcu-
lation, we contacted the authors asking for their data. If more versions of CBMwere used in a
study, these were averaged and sensitivity analyses were further conducted, using only one ES
per study (i.e., the one with the largest ES, and the one with the lowest). For studies with more
than one control group for the CBM intervention, we used only one control group to calculate
ES.We chose the group most similar to a placebo group (i.e., no contingency training), as this
was the most common control condition in CBM studies. This approach also reduces effect
size inflation attributable to non-specific effects of the intervention or to the fact that in some
cases the control condition was designed to achieve an opposite effect of increasing bias and
symptoms. We also calculated ESs at follow-up, since prevention of relapse is considered a par-
ticularly important strong point for CBM in addictions [12, 19].
To render results easier to interpret from a clinical point of view, we transformed the stan-
dardized mean difference (Hedges’ g) into numbers-needed-to-be-treated (NNT), using the
formulae of Kraemer & Kupfer [20]. The NNT represents the number of patients that would
have to be treated to generate one additional positive outcome compared to the control
group [21].
Given that we expected considerable heterogeneity among studies, we employed a random
effectsmodel [18] to calculate mean effect sizes. For the assessment of heterogeneity, we calcu-
lated the I2 statistic, indicating heterogeneity in percentages. A value of 0% indicates no
observedheterogeneity, whereas values over this refer to increasing heterogeneity, with 25% as
a threshold for low, 50% for moderate and 75% or above for high [22]. We calculated 95% con-
fidence intervals (CIs) around I2 [23], using the non-central χ2-based approach with the het-
erogi module for STATA [24]. Outliers were defined as studies in which the 95% CI was
outside the 95% CI of the pooled studies (on both sides).
Cognitive Bias Modification for Addictions
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We used a mixed effectsmodel for subgroup analyses. Under this model, studies within sub-
groups are pooled using the random effectmodel, while tests for significant differences between
subgroups are carried out using a fixed effectsmodel. For continuous moderator variables, we
usedmeta-regression analyses to examine whether there was a significant relationship between
each of these variables and the ES.
We assessed publication bias using three different procedures. First, we visually inspected
the asymmetry of the funnel plot. In the presence of bias, there will be a higher concentration
of studies at the lower right part of the plot [18]. Secondly, we used the Duval-Tweedie trim
and fill procedure [25] (as implemented in CMA, version 2.2.064, using a fixed effectsmodel
and searching for missing studies left of the mean), which gives an estimate of the ES after the
publication bias has been taken into account (adjusted effect size) and also indicates how many
studies were imputed to correct for publication bias. Thirdly, we conducted Egger’s test of the
intercept to test the symmetry of the funnel plot.
Results
Selection and inclusion of studies
We examined a total of 1092 records (682 after duplicates were removed) and excluded 632
based on the inspection of the abstract. We retrieved the full text of the remaining 50 articles.
Fig 1 presents the flowchart of the inclusion process and details the reasons for the exclusion of
trials, following the PRISMA statement [26]. This process resulted in 24 published studies
comprising of 25 RCTs that met our inclusion criteria and were included in the meta-analysis.
Characteristicsof included studies
The 25 RCTs included 34 relevant comparisons (see S2 File. for the complete list of included
studies). Most studies were recent, with the earliest one published in 2005, and the bulk of the
included studies (11) between 2012 and 2015. Eighteen trials focused on alcohol problems, and
7 on smoking. Twelve studies targeted attentional bias, while 8 targeted approach bias, 4
response inhibition and one focused on interpretation bias. The number of intervention ses-
sions ranged from 1 to 21, but 11 RCTs used only one session. Twenty RCTs focused on con-
sumers of a substance, 5 on clinical patients. Fifteen studies were based on interventions
carried out exclusively in the laboratory, 4 at home/the participant’s environment, one gave
participants a choice between the laboratory and home, and 5 in a mental health clinic. The fol-
low-up period ranged from 4 weeks to one year, with a mean of 6 months. Table 1 presents
selected characteristics of the included RCTs.
Risk of bias of the included studies
Overall, most of the included RCTs had high or uncertain risk of bias for most criteria. Only 4
studies out of 25 had low risk of bias for three or more of the criteria considered. Thirteen stud-
ies could be rated as low risk of bias on only one of the five criteria. Fig 2 presents the percent-
age of studies with a low, unclear (i.e., not enough information) and high risk of bias, for each
of the quality criteria. For blinding of outcome assessors, 23 trials used exclusively self-report
measures for addiction outcomes, and the other 2 employed proper blinding. For sequence
generation and allocation concealment, only three and respectively one trial could be rated as
having low risk of bias. For blinding of participants, an equal number of studies (8) had low
and respectively high RoB. For incomplete outcome data, the vast majority of studies (19/24)
had not employed methods to include drop-outs in the analysis. It is also worth mentioning
that for all criteria except blinding of assessors and incomplete data, the majority of RCTs did
Cognitive Bias Modification for Addictions
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Fig 1. Flowchartof selectionand inclusion process, following the PRISMAstatement.
doi:10.1371/journal.pone.0162226.g001
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Table 1. Selected characteristics of included studiesof cognitivebiasmodification interventions.
Studya Populationb Nrandc CBMd Controle Conc
Txf
Addiction
Measuresg
Bias
measureh
Di Nsj FUk
Attwood, 2008 Smokers ( 5 cig/
day)
55 ABM (VPT) ABM (attend
smoking)
- QSU-B; Craving
VAS
VPT L 1 -
Begh, 2015 Smokers trying to
quit (10 cig/day)
119 ABM (VPT) No cont NP MPSS-C;
MPSS-M; CO-
verified
abstinence
VPT; PST C 4 1,2,
3& 6
mths
Boendermaker,
2015 Study 1
Regular drinkers 77 Inhibition (Go/No
Go) (original/
gamified/social
No cont - Alcohol use
(TFLB)
Alcohol Go/
No Go
L/
H
3 -
Cox, 2015 Drinkers (14
units/wk-women;
21 units/wk-men)
148 AACTP No training - DRQ (MWD;
ATWD); SIP
Stroop Task L 4 3&6
mths
Eberl, 2013 Alcohol dependent
inpatients (CIDI)
509 A-AAT No training TAU
(CBT)
Relapse (DGSS-
4)
A-AAT C 12 1 year
Field, 2005 Drinkers (14
units/wk-women;
21 units/wk-men)
40 ABM (VPT) ABM (attend
alcohol)
- DAQ; Urge to
drink VAS
VPT L 1 -
Field, 2007 Drinkers (14
units/wk-women;
21 units/wk-men)
60 ABM (VPT) No cont: ABM
(attend alcohol)
- DAQ; Urge to
drink VAS
VPT; PST;
FICBT;
SRCT
L 1 -
Field, 2009 Smokers ( 1 cig/
wk)
72 ABM (VPT) No cont; ABM
(attend)
- QSU-B; Urge to
smoke VAS
VPT; PST L 1 -
Houben, 2011 Drinkers (10
units/wk-women;
12 units/wk-men)
52 Inhibition (Go/No
Go)
Go/NoGo (alcohol
for go)
Alcohol use
(TFLB)
IAT L 1 -
Houben, 2012 Drinkers (10
units/wk-women;
12 units/wk-men)
57 Inhibition (Go/No
Go)
Go/NoGo (alcohol
for go)
- Alcohol use
(TFLB)
SRCT; SST;
IAT
L 1 -
Kerst, 2014 Smokers (10 cig/
day)
65 ABM (VPT) No cont - QSU; Cig/day
(diary);CO (ppm);
Cotinine saliva
(ng/ml)
VPT H 21 -
Jones, 2013 St 1 Drinkers (14
units/wk-women;
21 units/wk-men)
90 Inhibition (SST) Inhibition (SST)
(neutral);
Disinhibition (SST
no stop)
- Alcohol use
(TFLB); AAAQ
SST L 1 -
Lindgren, 2015 St
1
Drinkers (1 heavy
drink ep 4–5
drinks past mth)
295 A-AAT (original/
general ident/
personalized
ident)
No cont (original/
general ident/
personalized ident)
- ACQ-SF-R;
Intention to drink
A-AAT L 2 -
Lindgren, 2015 St
2
Drinkers
(AUDIT > 8)
288 A-AAT (original/
general ident/
personalized
ident)
No cont (original/
general ident/
personalized ident)
- ACQ-SF-R;
Intention to drink
A-AAT L 2 -
Lopes, 2014 Smokers trying to
quit (5 cig > 30
days)
67 ABM (VPT) No cont; ABM+No
cont
Group
CBT
QSU-B; FTND;
Cig/day; CO(ppm)
VPT L 3 1, 6, &
12
mths
McGeary, 2014 Drinkers
(AUDIT > 8)
31 ABM (VPT) No cont - DHQ (1 item) VPT L
+H
9 -
McHugh, 2010 Smokers (10 cig/
day for 1 year)
64 ABM (VPT) No cont - QSU-B VPT L 1 -
Schoenmakers,
2007
Drinkers (> 20
units/wk; 1 binge
drinking ep in last 2
wks)
106 ABM (VPT) No cont - Craving VAS VPT; FICBT L 1 -
(Continued)
Cognitive Bias Modification for Addictions
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not provide the information necessary for assessing them (21/25 for sequence generation, 22/
25 allocation concealment, and 9/25 for blinding of participants). A risk of bias summary for
each included trial is presented in S1 Fig.
CBM, compared to a control condition: Power analysis
We were able to identify 24 RCTs with a mean number of 68 subjects (34 per condition) for
post-test outcomes, and 7 RCTs with a mean number of 136 (68 per condition) subjects for
Table 1. (Continued)
Studya Populationb Nrandc CBMd Controle Conc
Txf
Addiction
Measuresg
Bias
measureh
Di Nsj FUk
Schoenmakers,
2010
Alcohol dependent
inpatients (DSM-IV)
43 ABM (VPT) Categorization task CBT DAQ; Relapse VPT C 5 3
mths
Wiers CE, 2014 Alcohol dependent
inpatients (MINI)
36 A-AAT No cont - DAQ; AAAQ A-AAT C 6 -
Wiers RW, 2010 Drinkers
(AUDIT > 8)
42 A-AAT A-AAT (approach) - Urge to drink
(Likert)
A-AAT L 1 -
Wiers RW, 2011 Alcohol dependent
inpatients (CIDI)
214 A-AAT (explicit/
implicit)
No cont; WL TAU
(CBT)
Craving (Likert);
Relapse (DGSS-
4)
A-AAT C 4 1 yr
Wiers RW, 2015 Drinkers
(AUDIT > 8)
314 A-AAT (100%
/90% /explicit
100%); AACTP
No cont - Craving VAS;
AAAQ; Drinks/day
(TFLB)
A-AAT H 4 1 &2
mths
Wittekind, 2015 Smokers (ad hoc
online survey)
257 AAT; mAAT WL - CQSS; FTND;
CDS-12; OCSS
- H 1 -
Woud, 2015 Drinkers
(AUDIT > 8)
74 CBM-I CBM-I (alcohol) - Alcohol use
(TFLB); Urge to
drink (Likert)
Similarity
ratings
L 3 -
Note.
a St, study
b Cig, cigarette; Wk, Week; Mths, Months; CIDI, Composite International Diagnostic Interview; AUDIT, Alcohol Use Disorders Identification Test; ep,
episode; DSM-IV, Diagnostic and Statistic Manual IV; MINI, Mini International Neuropsychiatric Interview;
c Nrand, Number randomized
d CBM, cognitive bias modification; ABM, attention bias modification; VPT, Visual Probe Task; AACTP, Alcohol AttentionControl Training Program; SST,
Stop-Signal Task; ident, identity; A-AAT, Alcohol Approach-Avoidance Task; mAAT, modified Approach-Avoidance Task; CBM-I, cognitive bias modification
for interpretation;
e ABM, attention bias modification;No cont, No Contingency; SST, Stop-Signal Task; ident, identity; A-AAT, Alcohol Approach-Avoidance Task; WL,
Waitlist; CBM-I, cognitive bias modification for interpretation;
f Conc Tx, Concurrent Therapy; NP, Nicotine Patch; TAU, treatment as usual; CBT, cognitive behavior therapy
g QSU-B, Questionnaire of Smoking Urges-Brief; VAS, Visual Analogue Scale; MPSS (C/M),Mood and Physical SymptomsScore (Craving/Mood); DRQ,
DrinkingRecord Questionnaire; MWD, mean weekly drinking; ATWD, atypical weekly drinking; SIP, Short Index of Problems; DGSS-4, GermanSociety for
Addiction Research and Adddiction Medicine-4; DAQ, Desires for Alcohol Questionnaire; TFLB, Timeline Follow-Back Questionnaire; CO (ppm),expired
alveolar carbonmonoxide; AAAQ, Alcohol Approach Avoidance Questionnaire; ACQ-SF-R, Alcohol Craving Questionnaire—Short Form—Revised
questionnaire; FTND, Fagerström Test for Nicotine Dependence; DHQ, DrinkingHabits Questionnaire; CQSS, Commitment to Quitting Smoking Scale;
CDS-12, CigaretteDependence Scale-12; OCSS, Obsessive Compulsive Smoking Scale
h VPT, Visual Probe Task; A-AAT, Alcohol Approach-Avoidance Task; PST, Pictorial Stroop Task; IAT, Implicit Association Test; FICBT, Flicker-Induced
Change Blindness Task; SRCT, Stimulus-Response Compatibility Task; SST, Stop-Signal Task
i D, Delivery; L, Laboratory; H, Home; C, Clinic;
j Ns, Number of sessions;
k FU, Follow-up; Mth, month.
doi:10.1371/journal.pone.0162226.t001
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follow-up. According to our power analysis, this would allow us to evidence a small ES of 0.30
or more for post-test, but not for follow-up.
Posttest results- Addiction (all outcomes)
The effects of a CBM intervention were compared to a control condition in 25 RCTs, with 34
comparisons (Table 2). The mean ES was small and non-significant with g = 0.08 (95% CI
-0.02 to 0.18). Heterogeneity was low (I2 = 0%; 95% CI: 0–40). Results were similar when con-
sidering only established outcome measures, and respectively when excluding comparisons
where the control group received the opposite intervention (i.e., meant to increase bias). The
effects were non-significant in the four studies that employed CBM in addition to another
active intervention (physical or psychological), g = 0.06, 95% CI -0.16 to 0.28.
Fig 3 displays the forest plot of the standardized effect sizes of CBM interventions.
In four studies, more versions of CBMwere included, which meant that multiple compari-
sons from these studies were not independent from each other. Consequently, their indepen-
dent use in the same analyses could have affected the pooled ES through an artificial reduction
of heterogeneity. We conducted sensitivity analyses by including only one ES per study (first
the one with the largest ES, then the one with the lowest) to examine these possible effects. The
resulting ESs as well corresponding heterogeneity were very close to the ones found in the over-
all analysis, with the difference that the ES for the analysis including the comparisonmost
favorable for CBM from each study was small, but significant (g = 0.11, 95% CI 0.009 to 0.20).
The results were comparable when looking at alcohol and smoking dependence separately.
For alcohol outcomes, 17 trials resulted into a non-significant g of 0.10 (95% CI -0.01 to 0.22),
with zero heterogeneity (I2 = 0%, 95% CI: 0–45). For smoking, 7 RCTs aggregated in a non-sig-
nificant g of 0.02 (95% CI -0.15 to 0.20), with zero heterogeneity (I2 = 0%; 95% CI: 0–58).
Posttest results- Craving
Eighteen trials resulted in a non-significant g of 0.05 (95% CI -0.06 to 0.16), with zero heteroge-
neity (I2 = 0%) but a wider 95% CI (0–44). Results were similar when considering only one
comparison for the studies with more comparisons, for established outcome measures only,
when excluding comparisons with interventions aimed to increase bias, and for alcohol and
smoking outcomes taken separately (Table 2).
Fig 2. Risk of bias graph: review authors' judgmentsabout each risk of bias itempresented as percentages across all included
studies.
doi:10.1371/journal.pone.0162226.g002
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Table 2. Effects of CBM interventions, compared to control, at posttest and follow-up, for addictionoutcomesa.
Variable n g 95% CI I2 I2 95%CI NNT pb
Addiction (all measures) 24 0.08 -0.02 to 0.18 0 0~40 21.74
One ES per study (only highest) 24 0.11 0.009 to 0.20 0 0~40 16.13
One ES per study (only lowest) 24 0.05 -0.05 to 0.15 0 0~40 35.71
Established outcomemeasures only 21 0.09 -0.02 to 0.20 0 0~41 20
Comparisons with increase bias interventions excludedc 18 0.04 -0.07 to 0.15 0 0~44 45.45
Studies of CBM combined with another interventiond 4 0.06 -0.16 to 0.28 7 0~70 29.41
Subgroup analysise
Addiction type Alcohol 17 0.10 -0.01 to 0.22 0 0~45 17.86 0.459
Smoking 7 0.02 -0.15 to 0.20 0 0~58 83.33
Sample type Consumers 20 0.08 -0.03 to 0.19 0 0~42 21.74 0.979
Patients 4 0.07 -0.19 to 0.34 30 0~76 25
Delivery settingf Laboratory 15 0.07 -0.06 to 0.21 0 0~46 25 0.999
Home 4 0.07 -0.15 to 0.28 0 0~68 25
Clinic 4 0.07 -0.19 to 0.34 30 0~76 25
Bias targetedg Approach 7 0.07 -0.08 to 0.23 0 0~58 25 0.437
Attentional 12 0.03 -0.12 to 0.18 0 0~50 62.5
Inhibition 4 0.23 -0.04 to 0.50 0 0~68 7.69
Number of sessions Single 11 0.07 -0.07 to 0.21 0 0~51 25 0.867
Multiple 13 0.09 -0.05 to 0.22 0 0~49 20
Craving 18 0.05 -0.06 to 0.16 0 0~44 35.71
One ES per study (only highest) 18 0.08 -0.03 to 0.20 2 0~44 21.74
One ES per study (only lowest) 18 0.02 -0.09 to 0.14 0 0~44 83.33
Established outcomemeasures only 14 0.05 -0.09 to 0.19 0 0~49 35.71
Comparisons with increase bias interventions excludedh 14 0.02 -0.11 to 0.14 0 0~47 83.33
Studies of CBM combined with another interventiond 4 0.03 -0.32 to 0.38 56 0~83 62.5
Subgroup analysise
Addiction type Alcohol 12 0.07 -0.07 to 0.20 0 0~50 25 0.798
Smoking 6 0.03 -0.22 to 0.28 27 0~71 62.5
Sample type Consumers 14 0.05 -0.08 to 0.19 0 0~47 35.71 0.908
Patients 4 0.03 -0.32 to 0.38 56 0~83 62.5
Delivery setting Laboratory 12 0.06 -0.09 to 0.21 0 0~50 29.41 0.972
Home 2 0.02 -0.35 to 0.39 0 N/Ai 83.33
Clinic 4 0.03 -0.32 to 0.38 56 0~83 62.5
Bias targetedj Approach 6 0.10 -0.07 to 0.28 0 0~61 17.86 0.36
Attentional 10 -0.01 -0.19 to 0.16 11 0~58 166.67
Number of sessions Single 8 0.04 -0.15 to 0.22 0 0~56 45.45 0.895
Multiple 10 0.05 -0.10 to 0.21 10 0~57 35.71
Addiction (all measures)- follow-up 7 0.18 0.03 to 0.32 0 0~58 9.80
One ES per study (only highest) 7 0.18 0.04 to 0.32 0 0~58 9.80
One ES per study (only lowest) 7 0.16 0.02 to 0.31 0 0~58 11.11
Established outcomemeasures only 7 0.18 0.04 to 0.32 0 0~58 9.80
Studies of CBM combined with another interventiond 5 0.19 0.04 to 0.34 0 0~64 9.43
Subgroup analysise
Addiction type Alcohol 5 0.18 0.03 to 0.33 0 0~64 9.80 0.933
Smoking 2 0.16 -0.23 to 0.56 0 N/Ai 11.11
Sample type Consumers 3 0.09 -0.28 to 0.46 0 0~73 20 0.608
Patients 4 0.19 0.04 to 0.34 0 0~68 9.43
(Continued)
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Posttest results- Cognitive bias (all measures)
Nineteen RCTs resulted in a significant g of 0.60 (95% CI 0.39 to 0.79) (Table 3). Heterogeneity
was high (I2 = 64%; 95% CI: 36–77). Removal of 2 outliers reduced the ES to a g of 0.46 (95%
CI 0.30 to 0.62), with heterogeneity remaining small but with a large 95% CI.
Table 2. (Continued)
Variable n g 95% CI I2 I2 95%CI NNT pb
Bias targetedApproach 3 0.20 0.04 to 0.36 0 0~73 8.93 0.565
Attentional 4 0.10 -0.20 to 0.40 0 0~68 17.86
Note.
a All results are reported with Hedges g, using a random effects model
b The p levels in this column indicate whether the difference between the ESs in the subgroups is significant (significant results are marked with italic)
c Attwood et al., 2008; Field et al., 2005; Houben et al., 2011; Houben et al., 2012;WiersRW et al., 2010;Woud et al., 2015
d Begh et al., 2015; Lopes et al., 2014; Schoenmakers et al., 2010;Wiers et al., 2011
e Subgroup analysis were conducted using a mixed effects model.
f One study (Boendermarker et al. 2015 Study 1) gave participantsa choice between home and laboratorydelivery
g One study (Woud et al., 2015) used a different type of CBM (CBM for interpretation bias)
h Attwood et al., 2008; Field et al., 2005; WiersRW et al., 2010; Woud et al., 2015
i Confidence intervals around I2 cannot be calculated if there are fewer than 3 groups
j The subgroups targeting inhibition and respectively interpretation bias only had one study
n = number of trials; NNT = numbers needed to treat; N/A not available. UnderlinedNNT values indicate negative ES values (the direction of the effect
favored the control group)
doi:10.1371/journal.pone.0162226.t002
Fig 3. Standardized effect sizes of CBM interventions for addiction (all measures).
doi:10.1371/journal.pone.0162226.g003
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Follow-up results- Addiction (all outcomes)
Seven trials reported follow-up outcomes, resulting in a small but significant g of 0.18 (95% CI
0.03 to 0.32), with zero heterogeneity (I2 = 0%). Result were significant for alcohol related
addiction outcomes considered separately, g = 0.18, (95% CI 0.03 to 0.33), but not for smoking;
g = 0.16, (95% CI -0.24 to 0.56). Due to lack of data, we did not calculate ESs for craving and
bias. All follow-up trials involved multiple session CBM.While the studies had variable follow-
up duration, the mean follow-up time frame was 6 months.
Subgroup andmeta-regressionanalysis
Subgroup analyses (Tables 2 and 3) revealed no significant between groups differences for
addiction type, sample type, delivery setting, bias targeted. For addiction and craving outcomes
at post-test, ESs were non-significant in any of these subgroups. For bias outcomes, ES were
significant and highly heterogeneous in all subgroups. For number of sessions coded categori-
cally (single versus multiple), there were no significant differences for addiction and craving
outcomes, but for bias outcomes, studies with using a single session resulted in larger ESs than
studies using multiple sessions.
Meta-regression analysis indicated a significant negative relationship between the low RoB
score (number of criteria with low RoB) and ESs for addiction, slope b = -0.11, 95% CI -0.21 to—
Table 3. Effects of CBM interventions, compared to control, at posttest, for bias outcomesa.
Variable ncomp g 95%CI I2 I2 95% CI pb
Bias (all measures) 19 0.60 0.39 to 0.79 64 36~77
Outliers excludedc 17 0.46 0.310 to 0.62 39 0~65
Comparisons with increase bias interventions excludedd 13 0.46 0.25 to 0.68 58 7~76
Subgroup analysise
Addiction type Alcohol 14 0.59 0.37 to 0.80 59 12~76 0.927
Smoking 5 0.61 0.08 to 1.15 79 29–89
Sample type Consumers 15 0.64 0.39 to 0.89 69 40~80 0.324
Patients 4 0.44 0.12 to 0.75 42 0~80
Delivery settingf Laboratory 13 0.70 0.42 to 0.98 71 43~82 0.213
Clinic 4 0.44 0.12 to 0.75 42 0~80
Bias targetedg Approach 5 0.46 0.12 to 0.81 63 0~84 0.677
Attentional 9 0.65 0.32 to 0.98 68 18~82
Inhibition 4 0.70 0.13 to 1.27 76 0~89
Number of sessions: Single 9 0.86 0.53 to 1.18 68 17~82 0.007
Multiple 10 0.35 0.16 to 0.53 28 0~65
Note.
a All results are reported with Hedges g, using a random effects model
b The p levels in this column indicate whether the difference between the ESs in the subgroups is significant (significant results are marked with italic)
c Outliers were defined as studies in the 95% CI was outside the 95% CI of the pooled studies. (Above the 95%CI: Attwood et al., 2008; Jones et al., 2013)
d Attwood et al., 2008; Field et al., 2005; Houben et al., 2011; Houben et al., 2012;Wiers RW et al., 2010; Woud et al., 2015
e Subgroup analysis were conducted using a mixed effects model.
f One study employed delivery at home (Kerst and al., 2014) and another (Boendermarker et al. 2015 Study 1) gave participantsa choice between home and
laboratorydelivery
g One study (Woud et al., 2015) used a different type of CBM (CBM for interpretation bias)
n = number of trials
doi:10.1371/journal.pone.0162226.t003
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0.01; p = 0.026, and craving, slope b = -0.17, 95% CI -0.29 to—0.06; p = 0.001, at posttest (Fig 4).
The relationship was not significant for bias outcomes.
However, since only 3 studies met more than 3 criteria for low RoB, we ran the analysis
again excluding these studies. The relationship between risk of bias score and ES for addiction
(all outcomes), slope b = -0.12, 95% CI -0.25 to 0.004; p = 0.059, remained borderline signifi-
cant, while for craving, slope b = -0.17, 95% CI -0.33 to -0.002; p = 0.046, it was still significant.
There was no significant association between number of sessions and ESs for addiction, craving
or bias outcomes.
We also examined if the effects on cognitive bias were associated with the effects on addic-
tion outcomes. To this purpose, we ran a meta-regression analysis using computed ES for cog-
nitive bias as predictor and ESs on addiction (all measures) as dependent variable. The
Fig 4. Meta-regression analyses for the effects of low risk of bias score on effects sizes for 1) addiction (all
measures), and 2) craving.
doi:10.1371/journal.pone.0162226.g004
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relationship was not significant, neither in the analysis including all 19 trials that had data for
cognitive bias measures, slope b = 0.18, 95% CI -0.07 to 0.44, nor in the analysis excluding two
studies that were identified as outliers, slope b = 0.29, 95% CI -0.09 to 0.63.
Publication bias
Inspection of the funnel plot and the Duval-Tweedie trim and fill procedure documented some
publication bias for addiction (all measures), craving and bias at posttest. For addiction, after
adjusting for missing studies (n = 4), the ES decreased from a non-significant g of 0.07 to a non-
significant g of 0.04 (95% CI -0.05 to 0.14). Adjusting for missing studies (n = 2) led to a non-sig-
nificant g of 0.03, 95% CI -0.08 to 0.14, for craving. For bias, four studies were imputed, leading
to a smaller, but significant g of 0.40, 95% CI 0.17 to 0.64. Egger’s test was not significant for any
of these outcome categories (p> 0.05). For addiction outcomes at follow-up, the Duval-Tweedie
trim and fill procedure did not impute any studies, and Egger’s test was not significant (p> 0.05).
Discussion
CBM interventions have been viewed as holding particular promise for addiction problems,
particularly due to their assumed capacity of acting upon automatic, impulsive processes,
which are considered less amendable through traditional psychological interventions.While
previous narrative reviews were generally positive, with one critical exception [11], our meta-
analysis found no clinical benefits for these interventions at post-test, neither for all addiction
outcomes, nor for craving. Results remained remarkably similar when we looked at alcohol or
smoking-related outcomes separately, although CBM interventions have been viewed as espe-
cially effective for alcohol problems [9]. Subgroup analysis revealed a consistent pattern of
results, contradicting recent claims about the potential superior effectiveness of multiple ses-
sion CBM or when administered in the participant’s natural environment [11]. In fact, there
was no indication that CBMmight prove more efficient for certain types of applications or par-
ticipants. Trials where CBMwas administered in addition to another active intervention (e.g.,
cognitive behavioral therapy) were limited in number and also resulted in non-significant,
close to zero, effects for addiction and craving. This contradicts recent claims that CBMwould
be more effective as an add-on to other interventions [27]. We did find a small, significant
effect of CBM interventions at follow-up. However, we should be cautious in interpreting this
result, as it was based on solely 7 trials, which according to our power analysis was insufficient,
and all follow-ups were naturalistic making it difficult to attribute effects to interventions. This
small number was evenmore problematic given there was a lot of variability across these stud-
ies regarding the duration of follow-up, sometimes even within the same study, or the outcome
measures used.Moreover, a significant part of these trials did not conduct intent-to-treat anal-
yses, rendering the results vulnerable to selective attrition. Consequently, it is possible this
small effectmight also be due to drop-out before follow-up, the passing of time, or supplemen-
tary interventions being accessed by participants.
We did, however, find an opposite pattern of results for cognitive bias outcomes: ESs were
consistently large and significant and characterized by high heterogeneity, and this pattern was
maintained across all subgroups. The only exception was that number of sessions had a small,
but significant, negative association with ESs for bias: more sessions of CBMwere related to a
decrease in the magnitude of the effects on bias.
We found similar results (small and non-significant effects on symptom outcomes, but con-
siderable moderate to large effects on cognitive bias) in a meta-analysis of CBM interventions in
children and adolescents [7]. The consistency of this pattern for CBM interventions affords itself
to various interpretations. Firstly, it could be that these interventions have a genuine effect on
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bias, but this does not translate into effects on symptoms (with the potential exception of fol-
low-up measurements, which are arguably more important than post-test ones). Indeed, bias is
often accepted as a surrogate outcome for clinical benefits in CBM trials, but this substitution
could be unfounded. In support of this conjecture, our meta-regression results showed a non-
significant relationship between ESs for cognitive bias and ESs for addiction outcomes. As
results for bias were marked by high heterogeneity, this also indicates that some studies resulted
in positive outcomes for bias and others did not. Alternatively, it could also be that more time
may be needed for change of bias to be expressed in symptom change. While we did find a very
small but significant effect for follow-up addiction outcomes, this was based on only 7 trials,
and there were many differences as to the follow-up duration (4/6 trials had multiple follow-up
points), and no control as to what other interventions participants accessed during that period.
Importantly, in almost all these trials (5/7), participants also received another intervention
along with CBM,making it difficult to attribute beneficial effects to CBM. All but one of these 7
trials did not employ any measures of addressing missing data, rendering them vulnerable to
the effects of attrition bias. Most importantly however, trials with follow-up outcomes are few
and comemostly from the same research group. Independent replication throughmethodologi-
cally sound trials done by independent researchers would be needed before ascertainingwhether
CBMmight indeed be effective for addiction relevant outcomes at follow-up.
Finally, another explanation involves demand characteristics: as the task used for measuring
bias and respectively for conducting intervention is generally the same (e.g., the visual dot
probe or the approach-avoidance task), participants might simply be “getting better” at per-
forming it. This also dovetails with the peculiar result from our subgroup analyses, where mul-
tiple sessions of CBMwere associated with smaller ESs for cognitive bias than applications
with just one session; as well as with the fact that in 7 out of the 14 trials that explicitly reported
measuring contingency awareness, more than 50% of the participants (i.e., above chance)
guessed the purpose of the task. Whatever the explanation, our results found little indication
that positive effects on measures of cognitive bias translate to clinically relevant effects on
addiction outcomes, with the potential exception of follow-up measurements. Thus, our results
also contradict recent claims that the effectiveness of CBM interventions should only be evalu-
ated in studies that successfullymodify these biases [28].
To this point, we underscore that perhaps one of the most important problem our meta-
analysis revealed was the problematic (i.e., high or uncertain) risk of bias in trials of CBM for
addiction. Only 3 trials had low risk of bias for 3 or more of the 5 criteria we evaluated and
most studies did not report sufficient information to permit assessment of bias. More strik-
ingly, we showed a consistent pattern across addiction and craving outcomes of ESs decreasing
in inverse relationship with the study’s global score for low risk of bias (i.e., computed by giving
a point for each of the criteria considered on which the study could be rated as having low
RoB). Simply put, studies that had low risk of bias on more criteria seemed to consistently
result in smaller ESs. This pattern remained borderline significant for addiction (all outcomes)
and significant for craving when the studies with low RoB on 3 or more of the criteria consid-
ered were excluded. Moreover, there was consistent evidence of publication bias across all out-
come categories. Overall, trials of CBM for addiction have such a high or uncertain risk of bias
on most of the criteria we analyzed, that one might question whether any reliable conclusion
about the efficiencyof these interventions could be extracted from them.
Limitations
There are some limitations to our meta-analysis. One important one was small statistical
power, given by the reduced number of trials, particularly in comparison to the different
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versions of CBM tasks tested, and this might have prevented us from evidencing smaller mag-
nitude effects. Nonetheless, it is debatable whether such small effects could have any clinical
importance. Another problem was the consistently moderate or large confidence intervals for
I2, even when I2 was 0, indicating a heterogeneity was probably present, which most likely
affected pooled ESs [22]. Related to this, we note that most studies used a wide range of out-
comemeasurements and indices, focusing on various aspects of substance consumption or
dependence.We tried to alleviate this problem by conducting separate analysis looking only at
established, validated outcome measures and found similar results. Also, half of the trials were
single sessions applications, and while we did not find any differences between these and the
trials with more sessions, it could be argued that one session of CBM is unlikely to have thera-
peutic effects and such trials are less relevant in determining the efficiencyof these interven-
tions. Finally, most trials were focused on frequent or excessive consumers of a substance and
not on diagnosed addiction patients. While we analyzed patients separately and found no evi-
dence of an effect of CBM in this category, the number of trials was small and most of them
came from the same research group. Consequently, we cannot exclude the possibility that
more independent trials on dependent patients might result into a different pattern of results.
Future directions
In a singular critical review of CBM interventions for relapse prevention in addiction [10],
after pointing to methodological flaws and increasing negative results, the authors nonetheless
end on an optimistic tone, underscoring “we are at beginning of a journey, rather than at the
end” (p.49). Our results offer some possible suggestions for how this journey could continue.
Steps should be taken to minimize trial risk of bias (or to make it less uncertain) and demand
characteristics. Successfulmodification of cognitive bias, which authors of trials frequently
interpret as an accomplishment of the intervention, does not seem to be related to symptom
improvement. Consequently, trials with actual measures of symptom outcomes would be
needed to gauge actual therapeutic benefits. There was no indication that certain applications
of CBMwould be more beneficial than others or that certain types of addiction problems
would respond to these interventions better than to others. Therefore, constantly testing new
versions of CBM tasks and procedures is most likely unnecessary and the development of a
unified protocol to be used across more trials might be more suitable. The only area in which
CBM appeared to have an effect on addiction outcomes was at follow-up; however, the small
number of trials, high risk of attrition bias and their great variability render this result tentative.
Future trials with similar follow-up durations, testing similar CBM interventions and accompa-
nied by careful reporting of additional treatments participants might undergo during follow-
up could further clarify whether this effect remains consistent.
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